Article in nature.com on onvolytic viruses, page-4

Lopez
I agree - but what were the alternatives?? We were languishing out there on the market. Not one company bit, except Merck and Lepu valued us at 70 cents / share.
This was not after 2-3 years, this was after 12-15 years of business, countless conferences, trials, journal articles and raising. How many CEOs during this time - three?
Yes, we’ve been had and it’s a damn shame we didn’t get higher, but at least we got a deal and you made a fairly significant profit.